Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark · Delayed Price · Currency is DKK 2.570
-0.110 (-4.10%)
Sep 4, 2026, 1:39 PM CET
CPH:SMSMED Balance Sheet
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 1.45 | 2.15 | 11 | 7.92 | 27.76 | 25.4 |
Cash & Short-Term Investments | 1.45 | 2.15 | 11 | 7.92 | 27.76 | 25.4 |
Cash Growth | - | -80.46% | 38.89% | -71.48% | 9.30% | 138.24% |
Accounts Receivable | 16.58 | 22.72 | 21.16 | 14.97 | 6.93 | 1.05 |
Other Receivables | 5.68 | 5.36 | 3.01 | 5.92 | 1.49 | 1.75 |
Receivables | 22.25 | 28.07 | 24.17 | 20.89 | 8.42 | 2.81 |
Inventory | 100.68 | 109.74 | 84.58 | 85.93 | 56.18 | 16.13 |
Prepaid Expenses | 3.84 | 1.85 | 1.4 | 0.13 | 0.21 | - |
Other Current Assets | -0 | - | - | - | 0 | - |
Total Current Assets | 129.39 | 141.81 | 121.15 | 115.1 | 92.67 | 44.35 |
Property, Plant & Equipment | 65.86 | 62.64 | 51.85 | 48.27 | 13.15 | - |
Other Long-Term Assets | 1.43 | 1.41 | 1.11 | 0.6 | 0.31 | 0.3 |
Total Assets | 196.67 | 205.86 | 174.12 | 163.96 | 106.13 | 44.64 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Accounts Payable | 24.89 | 49.81 | 40.6 | 33.68 | 25.36 | 7.34 |
Short-Term Debt | 30.16 | 26.56 | 21.86 | 7.46 | 0.11 | - |
Current Portion of Leases | 8.77 | 6.62 | 4.03 | 3.45 | - | - |
Current Income Taxes Payable | 0.03 | 0.16 | 1.11 | 6.87 | 2.38 | 2.39 |
Current Unearned Revenue | 21.63 | 4.58 | 7.71 | 16.53 | 11.83 | 8.95 |
Other Current Liabilities | 3.3 | 3.29 | 2.02 | 3.83 | 0.65 | 1.86 |
Total Current Liabilities | 88.77 | 91.03 | 77.33 | 71.82 | 40.33 | 20.53 |
Long-Term Leases | 35.06 | 30.34 | 13.35 | 17.69 | - | - |
Long-Term Deferred Tax Liabilities | - | 1.83 | 0.95 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | 3.61 | - |
Total Liabilities | 123.83 | 123.19 | 91.63 | 89.51 | 43.94 | 20.53 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Common Stock | 1.11 | 1.11 | 1.1 | 1.09 | 1.09 | 0.85 |
Retained Earnings | 71.81 | 81.65 | 81.38 | 73.36 | 61.1 | 23.26 |
Comprehensive Income & Other | -0.08 | -0.09 | - | - | - | - |
Shareholders' Equity | 72.85 | 82.67 | 82.48 | 74.45 | 62.19 | 24.11 |
Total Liabilities & Equity | 196.67 | 205.86 | 174.12 | 163.96 | 106.13 | 44.64 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Total Debt | 73.98 | 63.53 | 39.24 | 28.6 | 0.11 | - |
Net Cash (Debt) | -72.53 | -61.38 | -28.25 | -20.69 | 27.66 | 25.4 |
Net Cash Growth | - | - | - | - | 8.88% | 140.25% |
Net Cash Per Share | -2.62 | -2.22 | -1.03 | -0.76 | 1.04 | - |
Filing Date Shares Outstanding | 27.81 | 27.69 | 27.5 | 27.32 | 27.25 | - |
Total Common Shares Outstanding | 27.81 | 27.69 | 27.5 | 27.32 | 27.25 | - |
Working Capital | 40.62 | 50.78 | 43.82 | 43.27 | 52.34 | 23.81 |
Book Value Per Share | 2.62 | 2.99 | 3.00 | 2.73 | 2.28 | - |
Tangible Book Value | 72.85 | 82.67 | 82.48 | 74.45 | 62.19 | 24.11 |
Tangible Book Value Per Share | 2.62 | 2.99 | 3.00 | 2.73 | 2.28 | - |
Machinery | 4.68 | 4.06 | 3.17 | 0.79 | 0.42 | - |
Construction In Progress | 13.27 | 13.35 | 10.64 | - | - | - |
Leasehold Improvements | 2.5 | 2.43 | 1.28 | 1.05 | 1.02 | - |